About Aerovate Therapeutics, Inc. 
Aerovate Therapeutics, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 25 Schemes (25.78%)
Foreign Institutions
Held by 34 Foreign Institutions (9.47%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Mar 2026)
Net Profit:
-40 Million
Pharmaceuticals & Biotechnology
USD 660 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.01
-25.74%
1.99






